MB and rhabdomyolysis: In conclusion, we advocate for a “paradigm shift” in managing severe rhabdomyolysis, recommending HA for CK levels >12,000 U/L and >10,000 ng/ml myoglobin, with column changes timed based on clinical condition and biomarker levels.